Welcome to LookChem.com Sign In|Join Free
  • or
10,11-dimethoxy-N-n-propylnoraporphine is a synthetic chemical compound belonging to the class of noraporphines, which are a group of alkaloids derived from the naturally occurring porphyrin macrocycle. This specific compound features two methoxy groups at the 10 and 11 positions and an N-n-propyl group, which is a three-carbon alkyl chain attached to the nitrogen atom. It is known for its potential applications in the field of medicinal chemistry, particularly in the development of drugs targeting the central nervous system. The compound's structure and properties make it a subject of interest for researchers exploring its pharmacological effects and potential therapeutic uses.

40285-10-7

Post Buying Request

40285-10-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

40285-10-7 Usage

Chemical classification

It is a chemical compound that belongs to the noraporphine family.

Type of compound

It is a type of alkaloid.

Source

It is derived from the plant species Annona purpurea.

Pharmacological properties

It has been studied for its potential pharmacological properties, including its ability to modulate dopamine receptors in the brain.

Therapeutic effects

It has been found to have potential therapeutic effects in the treatment of neurological disorders such as Parkinson's disease.

Anti-inflammatory properties

Research has shown that 10,11-dimethoxy-N-n-propylnoraporphine may have anti-inflammatory properties.

Neuroprotective properties

It may also have neuroprotective properties, making it a subject of interest for further study in the field of medicinal chemistry.

Further study

Due to its potential therapeutic effects and other properties, 10,11-dimethoxy-N-n-propylnoraporphine is a subject of interest for further research and development in the field of medicinal chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 40285-10-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,2,8 and 5 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 40285-10:
(7*4)+(6*0)+(5*2)+(4*8)+(3*5)+(2*1)+(1*0)=87
87 % 10 = 7
So 40285-10-7 is a valid CAS Registry Number.
InChI:InChI=1/C21H25NO2/c1-4-10-22-11-9-15-13-18(23-2)21(24-3)20-16-8-6-5-7-14(16)12-17(22)19(15)20/h5-8,13,17H,4,9-12H2,1-3H3

40285-10-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,2-dimethoxy-6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

1.2 Other means of identification

Product number -
Other names 4H-Dibenzo(de,g)quinoline,5,6,6a,7-tetrahydro-1,2-dimethoxy-6-propyl

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:40285-10-7 SDS

40285-10-7Relevant academic research and scientific papers

Aporphines. 48. Enantoselectivity of (R)-(-) and (S)-(+)-N-n-Propylnorapomorphine on Dopamine Receptors

Neumeyer, John L.,Reischig, Dirk,Arana, George W.,Campbell, Alexander,Baldessarini, Ross J.,et al.

, p. 516 - 521 (2007/10/02)

The enantiomers of N-n-propylnorapomorphine (NPA) were synthesized. (R)-NPA was obtained by the acid-catalyzed rearrangement of N-n-propylnormorphine. (R)-NPA also was converted to (RS)-N-n-propylnorapomorphine dimethyl ether by dehydrogenation of the 10,11-O,O'-dimethyl ether of (R)-NPA with 10percent palladium on carbon in acetonitrile, followed by reduction with sodium cyanoborohydride under acidic conditions.Alternatively (RS)-NPA 10,11-O,O'-dimethyl ether was obtained via total synthesis. (+)-Dibenzoyl-D-tartaric acid was used to resolve (RS)-NPA dimethyl ether.Ether cleavage gave (S)-NPA isolated as the hydrochloride salt in greater than 99.9percent enantiomeric purity, as determined by circular dichroism (CD) spectra.The pharmacological activities of (S)- and (R)-NPA were evaluated with subnanomolar concentrations of 3H-labeled apomorphine (APO), ADTN, and spiroperidol (SPR) for competition for binding to a membrane-rich subsynaptosomal fraction of calf caudate nucleus.IC50 (nM) values for (R)-NPA vs. (S)-NPA were as follows: 3>APO, 2.5 vs. 66; 3>ADTN, 2.0 vs. 60; 3>SPR, 174 vs. 1400.The efficacy of (R)- and (S)-NPA in stimulating dopamine-sensitive adenylate cyclase from both homogenates of rat corpus striatum and pieces of intact carp retina was also evaluated.Three behavioral effects in the rat (stereotyped behavior, sedation, and catalepsy) were also examined.Only (R)-NPA induced stereotypy; (S)-NPA failed to antagonize this action of the R isomer.The effects of (R)- and (S)-NPA on adenylate cyclase agreed with the behavioral effects and radioreceptor binding assays in that the R isomer was the strongly preferred enantiomer at dopamine receptors.The S enantiomer of NPA was, however, the weakly preferred configuration for rat liver catechol O-methyltransferase.A dopamine-receptor model accommodates the configuration of NPA and related aporphines

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 40285-10-7